Roche Diagnostics Korea Co.,Ltd. is engaged in manufacturing of pharmaceutical products. The company offers pharmaceutical products for anemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, drug metabolism disorder, gonorrhea, gout, hemostasis disorders, hepatitis B and C. In addition, Roche Diagnostics Korea Co.,Ltd. also distributes products for HIV/AIDS, human papillomavirus, infectious diseases, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid disorders, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases. The company operates as a subsidiary of Roche Holding AG. Roche Diagnostics Korea Co.,Ltd.was founded in 1990 and is based Seoul, South Korea.
Headquarters
22, Teheran-ro 108-gil Gangnam-gu Seoul
Seoul; Seoul;
Postal Code: 135502
Contact Details: Purchase the Roche Diagnostics Korea Co.,Ltd. report to view the information.
Website: http://www.roche-diagnostics.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service